These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 15906754)
1. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication. Niv Y Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754 [TBL] [Abstract][Full Text] [Related]
2. Comparison of proton pump inhibitor-based triple therapy with losec and the generic drug, Omepradex, for efficacy of Helicobacter pylori eradication. Niv Y Dig Dis Sci; 2005 Apr; 50(4):623-5. PubMed ID: 15844691 [TBL] [Abstract][Full Text] [Related]
3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole. Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617 [TBL] [Abstract][Full Text] [Related]
5. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. Harris AW; Misiewicz JJ; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387 [TBL] [Abstract][Full Text] [Related]
6. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Ahuja V; Dhar A; Bal C; Sharma MP Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815 [TBL] [Abstract][Full Text] [Related]
7. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544 [TBL] [Abstract][Full Text] [Related]
8. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. Miwa H; Ohkura R; Murai T; Sato K; Nagahara A; Hirai S; Watanabe S; Sato N Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502 [TBL] [Abstract][Full Text] [Related]
9. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori. Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974 [TBL] [Abstract][Full Text] [Related]
10. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829 [TBL] [Abstract][Full Text] [Related]
11. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520 [TBL] [Abstract][Full Text] [Related]
12. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection. Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090 [TBL] [Abstract][Full Text] [Related]
13. Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. Isomoto H; Inoue K; Furusu H; Nishiyama H; Shikuwa S; Omagari K; Mizuta Y; Murase K; Murata I; Kohno S Helicobacter; 2003 Apr; 8(2):111-9. PubMed ID: 12662378 [TBL] [Abstract][Full Text] [Related]
14. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519 [TBL] [Abstract][Full Text] [Related]
15. Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype. Inaba T; Mizuno M; Kawai K; Yokota K; Oguma K; Miyoshi M; Take S; Okada H; Tsuji T J Gastroenterol Hepatol; 2002 Jul; 17(7):748-53. PubMed ID: 12121503 [TBL] [Abstract][Full Text] [Related]
16. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Misiewicz JJ; Harris AW; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204 [TBL] [Abstract][Full Text] [Related]
17. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734 [TBL] [Abstract][Full Text] [Related]
18. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Fennerty MB; Kovacs TO; Krause R; Haber M; Weissfeld A; Siepman N; Rose P Arch Intern Med; 1998 Aug 10-24; 158(15):1651-6. PubMed ID: 9701099 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors]. Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498 [TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients. Shimoyama T; Munakata A; Mizuki I; Akagi T; Fukuda S; Ohkawa K; Yoshida Y; Aisawa T; Sakata Y; Fukushi M J Clin Gastroenterol; 1995; 20 Suppl 2():S125-7. PubMed ID: 7594328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]